Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Recruiting · NCT07169487 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study | Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndrome | Recruiting | Phase 1 | 2025-09-11 | NCT07169487 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital | Tianjin | China | 22 |